Creyon Bio

Creyon is a drug development company focused on enabling tissue-specific delivery of RNA therapies to enhance safety, efficacy, and patient experience in immunology, central nervous system (CNS), and neuromuscular diseases. The company is pioneering a new class of cell-specific therapeutics using aptamer-delivered oligonucleotides, which allow for... precise targeting of T and B cells. Creyon's innovative platform also facilitates the delivery of lipid nanoparticles to various cell types and has demonstrated the ability to cross the blood-brain barrier for CNS applications. With a strong pipeline and an AI-powered nucleic acid engineering platform, Creyon aims to revolutionize RNA drug design and improve treatment outcomes for patients.Read More